271 related articles for article (PubMed ID: 33844325)
1. Epigenetic and metabolic interplay in cutaneous squamous cell carcinoma.
Pacella G; Capell BC
Exp Dermatol; 2021 Aug; 30(8):1115-1125. PubMed ID: 33844325
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma.
Robinson DJ; Patel A; Purdie KJ; Wang J; Rizvi H; Hufbauer M; Ostano P; Akgül B; Chiorino G; Harwood CA; Bergamaschi D
J Invest Dermatol; 2019 Aug; 139(8):1658-1671.e8. PubMed ID: 30710576
[TBL] [Abstract][Full Text] [Related]
3. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
4. Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma.
Droll S; Bao X
Cell Physiol Biochem; 2021 Sep; 55(S2):89-119. PubMed ID: 34553848
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulatory mechanisms of histone acetylation in the treatment of cutaneous squamous cell carcinoma.
Joshi TP; Farr MA; Lewis DJ
Expert Opin Ther Targets; 2021 Nov; 25(11):1025-1026. PubMed ID: 34814792
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis.
Toutfaire M; Dumortier E; Fattaccioli A; Van Steenbrugge M; Proby CM; Debacq-Chainiaux F
Int J Biochem Cell Biol; 2018 May; 98():113-126. PubMed ID: 29550586
[TBL] [Abstract][Full Text] [Related]
7. METTL3 mediated m
Zhou R; Gao Y; Lv D; Wang C; Wang D; Li Q
Biochem Biophys Res Commun; 2019 Jul; 515(2):310-317. PubMed ID: 31153635
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk among p53 family members in cutaneous carcinoma.
Missero C; Antonini D
Exp Dermatol; 2014 Mar; 23(3):143-6. PubMed ID: 24417641
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
Li F; Liao J; Duan X; He Y; Liao Y
J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway.
Tian K; Liu W; Zhang J; Fan X; Liu J; Zhao N; Yao C; Miao G
Cell Mol Biol Lett; 2020; 25():12. PubMed ID: 32161621
[TBL] [Abstract][Full Text] [Related]
13. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.
Farsam V; Basu A; Gatzka M; Treiber N; Schneider LA; Mulaw MA; Lucas T; Kochanek S; Dummer R; Levesque MP; Wlaschek M; Scharffetter-Kochanek K
Oncotarget; 2016 Dec; 7(50):83554-83569. PubMed ID: 27907906
[TBL] [Abstract][Full Text] [Related]
14. USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1.
Chen L; Chen Q; Kuang S; Zhao C; Yang L; Zhang Y; Zhu H; Yang R
Cell Death Dis; 2019 Apr; 10(4):296. PubMed ID: 30931936
[TBL] [Abstract][Full Text] [Related]
15. Aberrant epigenetic regulation of RARβ by TET2 is involved in cutaneous squamous cell carcinoma resistance to retinoic acid.
Zhang X; Cong Y; Chu Z; Shi L; Zheng Y; Zhao Q; Geng S; Guo K
Int J Biochem Cell Biol; 2022 Apr; 145():106190. PubMed ID: 35248720
[TBL] [Abstract][Full Text] [Related]
16. miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1.
Zhou J; Zhang Y; Han Z; Dong Z; Cao T; Wei A; Guo P; Meng Q
Cell Cycle; 2019 Feb; 18(3):333-345. PubMed ID: 30646812
[TBL] [Abstract][Full Text] [Related]
17. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.
Wang J; Li C; Xu L; Yang C; Zhang X
Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic
Gualandi M; Iorio M; Engeler O; Serra-Roma A; Gasparre G; Schulte JH; Hohl D; Shakhova O
Life Sci Alliance; 2020 Jun; 3(6):. PubMed ID: 32312912
[TBL] [Abstract][Full Text] [Related]
19. Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma.
Zhao G; Bae JY; Zheng Z; Park HS; Chung KY; Roh MR; Jin Z
Anticancer Res; 2019 Apr; 39(4):1849-1857. PubMed ID: 30952725
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
